Moberg Pharma Granted U.S. Patent for Improved MOB-015 Dosing
Moberg Pharma announced that it was granted a U.S. patent relating to improved dosing of MOB-015.
Related stories
Generic Engineering Construction Q2 Net Profit INR 20.2 Million
M impact | EQUITY | Nov 03, 2026, 09:46 AM UTC
Zalando Q3 Revenue Rises 5.1% as B2B Revenue Jumps
Group revenue increased 5.1% to €3.17 billion and GMV rose 7.5% to €4.54 billion in the three months to September. B2B revenue jumped 27.9%. Zalando shares were up 1.9% at €27.51 i
M impact | EQUITY | Nov 03, 2026, 09:45 AM UTC
Zhongke Feice Chairman Proposes Share Buyback
Zhongke Feice said its controlling shareholder, chairman and general manager proposed repurchasing company shares for 1–1.5亿元.
L impact | EQUITY | Nov 03, 2026, 09:44 AM UTC
Rane (Madras) Reports Q2 Consolidated Revenue of INR 12,371.4 Million
M impact | EQUITY | Nov 03, 2026, 09:43 AM UTC
Rane (Madras) Reports Q2 Consolidated Net Profit of INR 3,266.8 Million
M impact | EQUITY | Nov 03, 2026, 09:43 AM UTC
SalMar Q3 Profit Jumps and Raises FY2026 Harvest Outlook
SalMar reported higher third-quarter profit year over year, supported by harvest volume growth, and raised its full-year 2026 harvest volume outlook.
M impact | EQUITY | Nov 03, 2026, 09:42 AM UTC